Compound Detail
CHEMBL49
BUSPIRONE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL49 |
| Name | BUSPIRONE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | QWCRAEMEVRGPNT-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
32
Targets
171
Activities
4
Assay Types
30
PK Parameters
20
Publications
4
Known Names
19
Indications
Molecular Properties
385.5
MW (Da)
2.09
ALogP
6
HBA
0
HBD
69.6
PSA (Ų)
0.55
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1986 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Anxiety Anxiety Disorders Apnea Dementia Depressive Disorder Ischemic Stroke Parkinson Disease Schizophrenia Attention Deficit Disorder with Hyperactivity Autistic Disorder Child Development Disorders, Pervasive Cocaine-Related Disorders Depressive Disorder, Major Gastroparesis Marijuana Abuse Sexual Dysfunction, Physiological Spinal Cord Injuries Dyspepsia Scleroderma, Systemic
ATC Classification
N05BE01
buspirone
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOLEPTICS
Activity Summary
Ki 102 meas. best 8.51
IC50 58 meas. best 8.15
EC50 9 meas. best 7.82
Kd 2 meas. best 8.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Ki | 8.51 | 7.827 | 3.1 | 33 |
| 5-hydroxytryptamine receptor 1A CHEMBL273 | Ki | 8.42 | 7.8742 | 3.8 | 24 |
| 5-hydroxytryptamine receptor 1A CHEMBL273 | IC50 | 8.15 | 7.6421 | 7.1 | 14 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Kd | 8.0 | 8.0 | 10.0 | 1 |
| D(2) dopamine receptor CHEMBL217 | Ki | 7.89 | 6.8825 | 13.0 | 8 |
| D(3) dopamine receptor CHEMBL234 | Ki | 7.82 | 7.0 | 15.0 | 2 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | EC50 | 7.82 | 7.2544 | 15.1 | 9 |
| 5-hydroxytryptamine receptor 1B CHEMBL3459 | Ki | 7.77 | 7.77 | 17.0 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | IC50 | 7.6 | 7.6 | 25.0 | 1 |
| Sigma non-opioid intracellular receptor 1 CHEMBL287 | IC50 | 7.44 | 6.7733 | 36.3 | 3 |
| D(2) dopamine receptor CHEMBL339 | Ki | 7.38 | 6.6425 | 41.7 | 8 |
| D(2) dopamine receptor CHEMBL3998 | Ki | 7.36 | 7.36 | 44.0 | 1 |
| D(3) dopamine receptor CHEMBL234 | IC50 | 7.36 | 7.36 | 44.0 | 1 |
| Sigma non-opioid intracellular receptor 1 CHEMBL3602 | Ki | 7.32 | 7.32 | 48.0 | 1 |
| D(2) dopamine receptor CHEMBL339 | IC50 | 7.26 | 6.7857 | 55.0 | 7 |
| Dopamine receptor CHEMBL2093868 | IC50 | 6.92 | 6.92 | 120.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | Ki | 6.86 | 6.5375 | 138.0 | 4 |
| Serotonin 2 (5-HT2) receptor CHEMBL2093870 | Ki | 6.76 | 6.27 | 174.0 | 3 |
| 5-hydroxytryptamine receptor 2A CHEMBL3446 | Ki | 6.75 | 6.75 | 178.0 | 1 |
| Sigma non-opioid intracellular receptor 1 CHEMBL287 | Ki | 6.67 | 6.67 | 212.0 | 1 |
| D(2) dopamine receptor CHEMBL217 | IC50 | 6.49 | 6.49 | 323.0 | 1 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | Ki | 6.32 | 6.32 | 477.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL322 | Ki | 6.32 | 6.32 | 482.0 | 2 |
| Alpha-1D adrenergic receptor CHEMBL223 | Ki | 6.28 | 6.28 | 529.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL2094251 | Kd | 6.24 | 6.24 | 575.4 | 1 |
| Unchecked CHEMBL612545 | Ki | 6.22 | 5.92 | 600.0 | 4 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Ki | 6.18 | 5.9133 | 653.0 | 3 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | IC50 | 6.12 | 6.12 | 750.0 | 1 |
| 5-hydroxytryptamine receptor 7 CHEMBL3155 | Ki | 6.08 | 6.08 | 840.0 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL324 | IC50 | 6.0 | 6.0 | 1000.0 | 1 |
| Alpha-1D adrenergic receptor CHEMBL223 | IC50 | 5.97 | 5.97 | 1077.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | IC50 | 5.85 | 5.59 | 1400.0 | 3 |
| Alpha-1A adrenergic receptor CHEMBL319 | Ki | 5.85 | 5.85 | 1410.0 | 1 |
| Multidrug and toxin extrusion protein 1 CHEMBL1743126 | IC50 | 5.77 | 5.77 | 1700.0 | 1 |
| Serotonin 2 (5-HT2) receptor CHEMBL2093870 | IC50 | 5.68 | 5.6067 | 2100.0 | 3 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | Ki | 5.64 | 5.64 | 2270.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | IC50 | 5.64 | 5.64 | 2286.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 5.47 | 5.235 | 3380.0 | 2 |
| Alpha-1A adrenergic receptor CHEMBL319 | IC50 | 5.46 | 5.46 | 3482.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.4 | 5.4 | 3981.1 | 1 |
| D(2) dopamine receptor CHEMBL3998 | IC50 | 5.4 | 5.4 | 4000.0 | 2 |
| D(1A) dopamine receptor CHEMBL2967 | Ki | 5.21 | 5.21 | 6100.0 | 1 |
| Adrenergic receptor alpha-2 CHEMBL2093864 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL3446 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
| Alpha-2A adrenergic receptor CHEMBL4744 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
| Solute carrier family 22 member 2 CHEMBL1743122 | IC50 | 4.92 | 4.92 | 12000.0 | 1 |
| 5-hydroxytryptamine receptor 1B CHEMBL3459 | IC50 | 4.9 | 4.74 | 12589.2 | 2 |
| Alpha-1A adrenergic receptor CHEMBL4892 | IC50 | 4.8 | 4.8 | 16000.0 | 1 |
| D(1A) dopamine receptor CHEMBL2967 | IC50 | 4.57 | 4.57 | 27000.0 | 1 |
| Multidrug and toxin extrusion protein 2 CHEMBL1743127 | IC50 | 4.34 | 4.34 | 46000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 19.2 | mL.min-1.kg-1 | Homo sapiens |
| CL | 148.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 38.9 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 116.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 28.0 | mL.min-1.kg-1 | Homo sapiens |
| Cmax | 10.38 | nM | Rattus norvegicus |
| Cmax | 378.72 | nM | Canis lupus familiaris |
| Cmax | 5.0 | nM | Homo sapiens |
| F | 1.0 | % | Rattus norvegicus |
| F | 9.0 | % | Canis lupus familiaris |
| F | 4.0 | % | Homo sapiens |
| Fu | 0.22 | - | Rattus norvegicus |
| Fu | 0.24 | - | Sus scrofa |
| Fu | 0.263 | - | Homo sapiens |
| Fu | 0.207 | - | Macaca fascicularis |
| Fu | 0.265 | - | Canis lupus familiaris |
| Fu | 0.209 | - | Cavia porcellus |
| Fu | 0.227 | - | Mus musculus |
| Fu | 0.181 | - | Rattus norvegicus |
| Fu | 0.214 | - | Not specified |
| Fu | 0.261 | - | Not specified |
| Fu | 0.277 | - | Not specified |
| Fu | 0.333 | - | Not specified |
| Fu | 0.258 | - | Rattus norvegicus |
| T1/2 | 0.07667 | hr | Homo sapiens |
| T1/2 | 2.0 | hr | Homo sapiens |
| T1/2 | 1.0 | hr | Rattus norvegicus |
| T1/2 | 1.0 | hr | Canis lupus familiaris |
| T1/2 | 0.5167 | hr | Homo sapiens |
| T1/2 | 0.06333 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine